Neurovations Clinical Research and Education

02/04/2025

We’re proud to offer Leqembi infusions at Neurovations, giving patients access to an FDA-approved treatment designed to slow the progression of Alzheimer’s disease. This innovative therapy provides hope for a brighter tomorrow for those living with Alzheimer’s and their families. 💜

If you or a loved one are interested in learning more about Leqembi infusions, contact us today. Together, we’re taking strides toward better brain health. Learn more at https://napapaininstitute.com/treatment-infusion-treatment-for-alzheimers-disease/.

Explore breakthrough Alzheimer's disease treatment with IV infusions at Napa Pain Institute. Leqembi offers hope, slowing disease progression with minimal side effects. Medicare covers treatment for eligible patients. Contact us to learn more.

02/01/2025

Time is precious, especially when facing Alzheimer's. Our new clinical study is exploring treatments that could potentially slow the progression of symptoms. Don’t wait—learn more about how you can get involved now.

01/31/2025

It's TBT, we added one from the archives! This little worker was always ready for work (or a treat)!

01/30/2025

Do you or someone you know suffer from migraine? Dr. Eric Grigsby provides in-depth detail on the RELIEV - CM2 migraine study in this brief webinar. Watch the video:https://www.youtube.com/watch?v=gQO5c8B8qUo

01/29/2025

Do you or someone you know have Lupus? Neurovations Research is looking for men and women ages 18 years or older that have been diagnosed with Lupus to take part in an investigational study. Call: 707-252-9606 to learn more!

01/28/2025

In addition to dry eyes and mouth, Sjogren's Syndrome symptoms often includes swollen glands and joint pain. Neurovations Research is now enrolling for a Sjogren's Study. Learn more at https://neurovationsresearch.com/sjogrens-study/ or call 707-252-9606.

01/23/2025

Chronic fatigue is one of the common symptoms of Lupus. Learn about the new Neurovations Research Study for Lupus. Medical care is paid for study participants. ->https://neurovationsresearch.com/lupus/

01/23/2025

Participate in a new study aimed at exploring the effectiveness of a treatment for Alzheimer's. Your involvement could help make crucial advancements in care and treatment. Join us today and make every moment count! Call 707-252-9606 to learn more or visit us at Neurovationsresearch.com.

01/17/2025

Dr. Eric Grigsby provides in-depth detail on the RELIEV - CM2 migraine study in this brief webinar. Watch the video: https://neurovationsresearch.com/migraine-study/

01/17/2025

At Napa Pain Institute, we’re proud to offer Leqembi infusions, a breakthrough treatment designed to slow the progression of Alzheimer’s disease. To learn more about how Leqembi infusions can make a difference, contact us today! https://napapaininstitute.com/treatment-infusion-treatment-for-alzheimers-disease/

01/15/2025

New Neurovations Research Study for Lupus. We are looking for men and women ages 18 years or older that have been diagnosed with lupus to take part in an investigational study. Learn more at https://neurovationsresearch.com

01/10/2025

TMS therapy uses magnetic pulses to stimulate nerve cells in the brain, specifically targeting areas involved in mood regulation. This can be a game-changer for individuals with Major Depressive Disorder (MDD) who haven't found success with medications.